1. Benes P., Vashishta A., Saraswat-Ohri S., Fusek M., Pospisilova S., Tichy B., Vetvicka V.: Effect of procathepsin D activation peptide on gene expression of breast cancer cells. Cancer Lett., 2005, E-pub Sep 13. IF 2,9382.
2. Boudny V, Dusek L, Adamkova L, Chumchalova J, Kocak I, Fait V, Lauerova L,Krejci E, Kovarik J.: Lack of STAT 1 phosphorylation at TYR 701 by IFNgamma correlates with disease outcome in melanoma patients. Neoplasma, 52, 2005, 4:330-7. IF 0,822
3. Buchler T, Krejčí M, Svobodník A, Adam Z, Minařík J, Bačovský J, Ščudla V, Mayer J, Vorlíček J, Hájek R: Outcome of patients with multiple myeloma and hypertension treated with angiotensin-I-converting enzyme inhibitors during high-dose chemoterapy. The Hematology Journal, 5, 2005, 559-564. IF 4,191
4. Crawley Ch., Szydlo R., Vitek A., Mayer J., et. al.: Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT. Blood, 106, 2005, 9: 2969-2976. IF 9,782
5. Doubek M, Brychtova Y, Tomiska M, Mayer J: Idiopathic Systemic Capillary Leak Syndrome Misdiagnosed and Treated as Polycythemia vera. Acta Heamatol, 113, 2005, 1: 150-151. IF 1,373
6. Doubek M, Mayer J, Lauschová I, Scheer P, Krejcirova L, Horky D, Doubek J: Comparison of the effect of amphotericin B desoxycholate and amphotericin B colloidal dispersion on renal functions and renal morphology in rats. Nephrology, 10, 2005, 1: 57-62. IF 0,278
7. Doubek M., Brychtova Y., Borkovcova J., Krejci M., Palasek I., Dvořákova D., Mayer J.: Acute myeloid leukemias with reccurent genetic abnormalities: frequent assessment of minimal residual disease and treatment of molecular relapse with chemotherapy. Leukemia, 19, 2005, 5: 885-888. IF 5,81
8. Doubek M., Palasek I., Brychtova Y., Mayer J.: Acute myeloid leukemia treatment in patients over 60 years of age. Comparison of symptomatic, palliative, and aggressive therapy. Neoplasma, 52, 2005, 2: 411-414. IF 0,822
9. Dvorak P., Dvorakova D., Koskova S., Vodinska M., Najvirtova M., Krekac D., Hampl A.: Expression and Potential Role of Fibroblast Growth Factor 2 and Its Receptors in Human Embryonic. Stem Cells, 23, 2005, 9: 1200-1211. IF 5,5
10. Elbl L, Hrstkova H, Tomaskova I, Blazek B, Michalek J. Long-term serial echocardiographic examination of late anthracycline cardiotoxicity and its prevention by dexrazoxane in pediatric patients. Eur J Pediatr 164, 2005, 11: 678-684. IF 1,369
11. Chaloupka V, Elbl L, Nehyba S, Tomaskova I, Jedlicka F: Exercise intensity prescription for men after myocardial infarction who are treated with beta-blockers. J Cardiopulm Rehab 25, 2005, 6: 361-365. Bez IF
12. Krejci M., Buchler T., Hajek R., Svobodnik A., Krivanova A., Pour L., Adam Z., Mayer J., Vorlicek J.: Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple myeloma patients. Bone Marrow transplantation 35, 2005, 159-164. IF 2,1013. Krejci M., Doubek M., Buchler T., Brychtova Y., Vorlicek J., Mayer J.: Mycophenolate mofetil for treatment of acute and chronic steroid-refractory graft-versus-host disease. Annals of Hematology, 84, 2005, 681-685. IF 1,292
14. Ludwig H., Spicka I., Klener P., Greil R., Adam Z., et. al.: Continuous prednisolone versus conventional prednisolone with VMCP-interferon-α2b as first-line chemotherapy in elderly patients with multiple myeloma. Brithish Journal of Hematology, 131, 2005, 329-337. IF 3,195
15. Lukášová E., Kořistek Z., Falk M., Kozubek S., Grigoryev S., Kozubek M., Ondřej V., Kroupová I.: Methylation of histones in myeloid leukemias as a potential marker of granulocyte abnormalities. Journal of Leukocyte Biology 77, 2005, 1: 100-111. IF 4,224
16. Mayer J, Krejčí M, Doubek M, Pospíšil Z, Brychtová Y, Tomíška M, Ráčil Z: Pulse cyclophosphamide for corticortesteroid-refractory graft-versus-host disease. Bone Marrow Transplantation 35,2005, 1: 699-705. IF 2,101
17. Smardova L., Engert A., Haverkamp H., et. al.: Successful mobilization of peripheral blood stem cells with the DHAP regimen (dexamethasone, cytarabine, cisplatium) plus granulocyte colony-stimulating factor in pacients with relapsed Hodgkin´s disease. Leukemia & Lymphoma, 46, 2005, 7: 1017-1022. IF 1,147
18. Škapová D., Ráčil Z., Dvořáková D., Minaříková D., Mayer J.: Significance of qualitative PCR detection Metod for preemtive therapy of cytomegalovirus i nfection in patiens after allogeneic hematopoietic stem cell transplantation – single-centre experience. Neoplasma, 52, 2005, 2: 137-142. IF 0,822
19. Škopková Z, Hrabincová E, Šťastná S, Kozák L, Adam T: Molecular genetics analysis of SLC3A1 and SLC7A9 genes in Czech and Slovak cystinuric patients. Annals of Human Genetics 69, 2005: 501-507. IF 2,6820. Thakurta AG, Gopal G, Yoon JH, Kozák L, Dhar R: Homolog of BRCA2-interacting Dss1p and Uap56p link Mlo3p and Rae1p for mRNA export in fission yeast. EMBO Journal 24, 2005, 14: 2512-2523. IF 10,49221. Vrabelova S, Letocha O, Borsky M, Kozak L: Mutation analysis of the ATP7B gene and genotype/phenotype correlation in 227 patients with Wilson disease. Molecular Genetics and Metabolism 86, 2005, 1-2: 277-285. IF 2,502